FATTA, ERIKA
 Distribuzione geografica
Continente #
EU - Europa 3.046
NA - Nord America 1.928
AS - Asia 1.776
Continente sconosciuto - Info sul continente non disponibili 326
SA - Sud America 116
AF - Africa 39
OC - Oceania 5
Totale 7.236
Nazione #
US - Stati Uniti d'America 1.837
GB - Regno Unito 1.177
CN - Cina 583
DE - Germania 449
SG - Singapore 444
IT - Italia 377
SE - Svezia 292
RU - Federazione Russa 240
HK - Hong Kong 163
BD - Bangladesh 128
UA - Ucraina 116
FR - Francia 113
TR - Turchia 111
VN - Vietnam 108
IN - India 101
NL - Olanda 98
KR - Corea 66
BR - Brasile 63
CA - Canada 61
EU - Europa 58
PL - Polonia 50
IE - Irlanda 44
FI - Finlandia 43
CO - Colombia 34
JP - Giappone 20
CI - Costa d'Avorio 19
VE - Venezuela 9
DK - Danimarca 7
GR - Grecia 7
ID - Indonesia 7
PH - Filippine 7
RO - Romania 7
BE - Belgio 5
JM - Giamaica 5
MX - Messico 5
PK - Pakistan 5
AT - Austria 4
AU - Australia 4
CR - Costa Rica 4
ES - Italia 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
AR - Argentina 3
GE - Georgia 3
GT - Guatemala 3
IQ - Iraq 3
IR - Iran 3
JO - Giordania 3
MA - Marocco 3
PT - Portogallo 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
CL - Cile 2
CZ - Repubblica Ceca 2
EG - Egitto 2
HN - Honduras 2
KE - Kenya 2
MY - Malesia 2
NP - Nepal 2
PY - Paraguay 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
BY - Bielorussia 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GH - Ghana 1
HU - Ungheria 1
KG - Kirghizistan 1
LT - Lituania 1
LU - Lussemburgo 1
MK - Macedonia 1
MN - Mongolia 1
MQ - Martinica 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
RE - Reunion 1
RS - Serbia 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
YE - Yemen 1
Totale 6.970
Città #
Southend 1.091
Singapore 265
Ashburn 192
Chandler 182
Hong Kong 153
Beijing 152
Milan 120
San Jose 105
Seattle 95
Jacksonville 89
Princeton 73
Frankfurt am Main 62
Mountain View 58
Dearborn 57
Santa Clara 55
Dallas 51
Los Angeles 50
Munich 48
Warsaw 47
Redmond 46
Serra 46
Bengaluru 45
Nanjing 45
Ann Arbor 44
Dublin 44
Wilmington 42
Council Bluffs 40
Ho Chi Minh City 40
New York 40
Phoenix 40
Somerville 40
Boardman 39
Toronto 34
Bogotá 32
Andover 31
Sakarya 31
Lauterbourg 30
Buffalo 27
Hanoi 25
Des Moines 22
Moscow 22
Saint Petersburg 22
Shanghai 22
Fuzhou 21
Rome 21
Woodbridge 19
Abidjan 18
Tokyo 18
Jinan 17
Guangzhou 16
Hefei 16
Kiez 14
Nürnberg 14
Bitonto 13
Cangzhou 13
Tianjin 12
Bologna 10
Changsha 10
Chicago 9
Eitensheim 9
Shenyang 9
Grafing 8
Hangzhou 8
Hebei 8
Montreal 8
Nanchang 8
The Dalles 8
Wuhan 8
Athens 7
Atlanta 7
Da Nang 7
Fairfield 7
Jiaxing 7
São Paulo 7
Zhengzhou 7
Brooklyn 6
Haikou 6
Hamburg 6
Helsinki 6
Kunming 6
London 6
Noginsk 6
San Diego 6
Stockholm 6
Turin 6
Amsterdam 5
Boston 5
Brussels 5
Rio de Janeiro 5
San Francisco 5
Turku 5
Verona 5
Charlotte 4
Chengdu 4
Denver 4
Düsseldorf 4
Hillsboro 4
Houston 4
Lanzhou 4
Lissone 4
Totale 4.285
Nome #
Maintained long-term suppression of HBV replication in NUC-naïve patients with chronic hepatitis B treated with ETV monotherapy in field practice : the Italian multicenter experience 400
Risk of NASH and severe fibrosis in patients with NAFLD and low visceral adiposity 275
Variables significantly associated with non alcoholic steatohepatitis (NASH) and fibrosis in patients with non alcoholic fatty liver disease (NAFLD) 258
Cell-free DNA in HCV-related cirrhosis and small hepatocellular carcinoma 254
Cell-free DNA in HCV-related cirrhosis and small hepatocellular carcinoma 248
Risk of early atherosclerosis by carotid artery intima-media thickness in patients with non-alcoholic fatty liver disease and low visceral adiposity 239
Progression of carotic atherosclerotic damage is related to alt values in patients with non alcoholic fatty liver disease 238
Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patients 237
The risk of severe liver disease in NAFLD with normal amino-transferase levels : a role for insulin and diabetes 237
Risk of early atherosclerosis by carotid artery intima- media thickness in patients with non alcoholic fatty liver disease and low visceral adiposity 236
Interaction between lifestyle changes and PNPLA3 genotype in NAFLD patients during the COVID-19 lockdown 233
A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia 228
Increased ferritin predicts vascular damage in patients with nonalcoholic fatty liver disease 227
Entecavir is an effective treatment for NUC-naive chronic hepatitis B patients in clinical practice : 48-week data from a large multicenter cohort study 226
Increased ferritin predicts vascular damage in patients with nonalcoholic fatty liver disease 222
Progression of carotic atherosclerotic damage is related to ALT values 219
Effectiveness of entecavir for the treatment of NUC-naïve chronic hepatitis B patients : A large multicenter cohort study in clinical practice 217
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels : a role for insulin resistance and diabetes 208
Ferro, steatosi e... 205
Effectiveness of entecavir for the treatment of nuc-naïve chronic hepatitis B patients : a large multicenter cohort study in clinical practice 200
Entecavir for nuc-naïve chronic hepatitis B patients in clinical practice : long-term effectiveness from a large multicenter cohort study in 376 patients 197
Effectiveness of Entecavir for the treatment of NUC-naïve chronic hepatitis B patients : a large multicenter cohort study in clinical practice 195
Risk of NASH and severe fibrosis in patients with NAFLD and low visceral adiposity 194
Baseline alt and ferritin predict histological findings in NAFLD 182
Contrast-enhanced ultrasonography (CEUS) and spiral computed tomography (CT) in the assessement of efficacy of percutaneous ablation treatments of hepatocellular carcinoma in cirrhosis 180
Baseline alt and ferritin predict histological findings in NAFLD 171
Iron depletion by phlebotomy improves liver transaminases in patients with nonalcoholic fatty liver disease : a propensity score adjusted analysis 171
Evaluation of patients with NAFLD with or without increased ALT 169
Entecavir for nuc-naïve chronic hepatitis b patients in clinical practice : long-term effectiveness from a large multicenter cohort study in 376 patients 167
Normal ALT NAFLD should not preclude liver biopsy 164
Normal ALT should not preclude liver biopsy in patients with NAFLD 161
Effectiveness of Entecavir for NUC-naïve, HBeAg-negative chronic hepatitis B patients in clinical practice : a 2-year multicenter cohort study in 311 patients 160
Effectiveness of entecavir for NUC-naïve, HBeAg-negative chronic hepatitis B patients in clinical practice : a 2-year multicenter cohort study in 311 patients 151
Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP) 122
Low lysosomal acid lipase activity is associated with histological progression of metabolic dysfunction-associated steatotic liver disease 45
Totale 7.236
Categoria #
all - tutte 18.225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.225


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022365 17 8 7 34 8 17 40 39 40 55 33 67
2022/2023530 61 65 49 45 72 113 4 33 65 2 16 5
2023/2024308 5 26 19 10 137 18 3 21 1 10 27 31
2024/2025756 34 65 25 76 35 24 14 60 48 90 70 215
2025/20261.668 176 85 148 112 157 91 168 72 152 178 178 151
2026/2027110 110 0 0 0 0 0 0 0 0 0 0 0
Totale 7.236